Zomedica Pharmaceuticals Corp Tangible Net Worth Ratio
Zomedica Pharmaceuticals Corp tangible net worth ratio. Zomedica Pharmaceuticals Corp (ZOM) has a Tangible Net Worth Ratio of 67.7% as of March 2025. This metric is calculated by deducting intangible assets ($42.77 Million) from net assets ($132.44 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Zomedica Pharmaceuticals Corp equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Zomedica Pharmaceuticals Corp (2012–2024)
Tangible net worth ratio of Zomedica Pharmaceuticals Corp from 2012 to 2024. This chart shows how Zomedica Pharmaceuticals Corp's Tangible Net Worth Ratio has changed across 13 annual periods from 2012 to 2024. As of March 2025, the ratio stands at 67.7%, reflecting net assets of $132.44 Million with intangible assets of $42.77 Million USD. Check how strategically is Zomedica Pharmaceuticals Corp's equity deployed to assess the company's strategic physical and investment asset allocation.
Zomedica Pharmaceuticals Corp Tangible Net Worth Ratio by Year (2012–2024)
Zomedica Pharmaceuticals Corp tangible net worth ratio by year from 2012 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Zomedica Pharmaceuticals Corp from 2012 to 2024, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Zomedica Pharmaceuticals Corp market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 73.1% | $195.66 Million | $52.54 Million | $207.36 Million | ▼ -3.8 pp |
| 2023 | 76.9% | $240.02 Million | $55.36 Million | $253.20 Million | ▼ -7.4 pp |
| 2022 | 84.4% | $267.39 Million | $41.80 Million | $279.61 Million | ▼ -3.3 pp |
| 2021 | 87.6% | $270.89 Million | $33.52 Million | $280.40 Million | ▼ -11.6 pp |
| 2020 | 99.3% | $51.07 Million | $376.59K | $66.14 Million | ▲ +25.2 pp |
| 2019 | 74.1% | $2.10 Million | $543.39K | $4.18 Million | ▼ -25.6 pp |
| 2018 | 99.6% | $3.66 Million | $13.06K | $6.03 Million | ▼ 0.0 pp |
| 2017 | 99.7% | $4.39 Million | $15.14K | $5.22 Million | ▲ +7.3 pp |
| 2016 | 92.3% | $4.13 Million | $317.94K | $4.88 Million | ▲ +0.7 pp |
| 2015 | 91.6% | $3.71 Million | $311.02K | $3.86 Million | ▼ -8.4 pp |
| 2014 | 100.0% | $141.41K | $0.00 | $145.34K | ▲ +0.0 pp |
| 2013 | 100.0% | $206.38K | $0.00 | $211.54K | ▲ +0.0 pp |
| 2012 | 100.0% | $96.34K | $0.00 | $97.31K | — |